Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Mukhopadhyay S, et al. Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 17(3): 291-300, 1999. PubMed: 9987166
Mukhopadhyay S, et al. Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis. Clin. Diagn. Lab Immunol. 7(2): 233-240, 2000. PubMed: 10702498
Pucadyil TJ, et al. Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol. Biochem. Parasitol. 133(2): 145-152, 2004. PubMed: 14698427
